Ting Xu

4.7k total citations · 1 hit paper
186 papers, 3.4k citations indexed

About

Ting Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ting Xu has authored 186 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 35 papers in Pulmonary and Respiratory Medicine and 34 papers in Oncology. Recurrent topics in Ting Xu's work include Head and Neck Cancer Studies (12 papers), Epigenetics and DNA Methylation (11 papers) and MicroRNA in disease regulation (10 papers). Ting Xu is often cited by papers focused on Head and Neck Cancer Studies (12 papers), Epigenetics and DNA Methylation (11 papers) and MicroRNA in disease regulation (10 papers). Ting Xu collaborates with scholars based in China, United States and Australia. Ting Xu's co-authors include Zhiyao He, Bin Wu, Yuquan Wei, Cuicui Ma, Zicheng Xu, Hongzhou Cai, Weiqi Hong, Li Chen, Wenyan Ren and Zhiyong Qian and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Ting Xu

170 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent progress in targeted delivery vectors based on biomimetic nanoparticles

2021 258 citations Li Chen, Weiqi Hong et al. Signal Transduction and Targeted Therapy profile →

Peers

Ting Xu

MB

ONCOL

CR

SURGE

PRM

Hyun‐Ah Kim South Korea

Jie Cao China

Yan D. Zhao United States

Suradej Hongeng Thailand

Weiwei Wang China

William W. Li United States

Philippe Gillery France

Myungshin Kim South Korea

Ardeshir Ghavamzadeh Iran

Hongcui Cao China

Hyun‐Ah Kim South Korea

Ting Xu

1.5k ×1.1

MB

868 ×1.5

ONCOL

847 ×1.7

CR

617 ×1.4

SURGE

362 ×1.0

PRM

Citations per year, relative to Ting Xu Ting Xu (= 1×) peers Hyun‐Ah Kim

Countries citing papers authored by Ting Xu

Since Specialization

Citations

This map shows the geographic impact of Ting Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Xu more than expected).

Fields of papers citing papers by Ting Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ting Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Xu. The network helps show where Ting Xu may publish in the future.

Co-authorship network of co-authors of Ting Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ting Xu. A scholar is included among the top collaborators of Ting Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Xu. Ting Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Xue, Wei, Huixin Liu, Fang Chen, et al.. (2025). Multi-Component Botanical Crude Extracts Improve Egg and Meat Quality in Late-Laying Hens Through Gut Microbiota Modulation. Foods. 14(20). 3480–3480.

2.

Zhan, Mei, Qi Long, Jinhan He, et al.. (2025). Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors. Frontiers in Immunology. 16. 1499074–1499074. 2 indexed citations

3.

Xu, Ting, et al.. (2024). Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report. Diagnostic Pathology. 19(1). 69–69.

4.

Wan, Dahang, Rongsheng Lu, Bingtao Hu, et al.. (2024). YOLO-MIF: Improved YOLOv8 with Multi-Information fusion for object detection in Gray-Scale images. Advanced Engineering Informatics. 62. 102709–102709. 49 indexed citations

5.

Xu, Ting, et al.. (2024). Strategies for developing μ opioid receptor agonists with reduced adverse effects. Bioorganic Chemistry. 149. 107507–107507. 1 indexed citations

6.

Wen, Lingyi, Xiaomin Fu, Huan Zhang, et al.. (2024). Tailoring Zinc Ferrite Nanoparticle Surface Coating for Macrophage-Affinity Magnetic Resonance Imaging of Atherosclerosis. ACS Applied Materials & Interfaces. 16(11). 13496–13508. 14 indexed citations

7.

Zhou, Hetong, Minmin Wang, Ting Xu, et al.. (2024). Cognitive Remediation in Patients With Bipolar Disorder: A Randomized Trial by Sequential tDCS and Navigated rTMS Targeting the Primary Visual Cortex. CNS Neuroscience & Therapeutics. 30(12). e70179–e70179. 2 indexed citations

8.

Xu, Ting, Chang Zhang, Yufeng Yang, et al.. (2024). Role of Milk Intake in Modulating Serum Lipid Profiles and Gut Metabolites. Metabolites. 14(12). 688–688.

9.

Huang, Li, et al.. (2023). Akt/mTOR Pathway Agonist SC79 Inhibits Autophagy and Apoptosis of Oligodendrocyte Precursor Cells Associated with Neonatal White Matter Dysplasia. Neurochemical Research. 49(3). 670–683. 2 indexed citations

10.

Tian, Fangyuan, et al.. (2023). Developing a Warning Model of Potentially Inappropriate Medications in Older Chinese Outpatients in Tertiary Hospitals: A Machine-Learning Study. Journal of Clinical Medicine. 12(7). 2619–2619. 8 indexed citations

11.

Ye, Feng, Ting Xu, Ziyi Wu, et al.. (2023). Do all patients at the initial stage of nasopharyngeal carcinoma need bone metastasis screening? A retrospective study. Head & Neck. 45(6). 1476–1485. 1 indexed citations

12.

Liu, Ye, et al.. (2023). [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].. PubMed. 58(10). 755–765.

13.

Chen, Li, Weiqi Hong, Wenyan Ren, et al.. (2021). Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal Transduction and Targeted Therapy. 6(1). 225–225. 258 indexed citations breakdown →

14.

Wu, Bin, et al.. (2019). Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method. International Journal of Clinical Pharmacy. 41(5). 1174–1183. 12 indexed citations

15.

Zhou, Lingyan, et al.. (2019). Current RNA-based Therapeutics in Clinical Trials. Current Gene Therapy. 19(3). 172–196. 87 indexed citations

16.

Li, Xiao, Ran You, Xinwei Wang, et al.. (2016). Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review. Clinical Cancer Research. 22(15). 3971–3981. 137 indexed citations

17.

Zhu, Ranran, Ting Wang, Ting Xu, et al.. (2013). [Expressions and clinical significance of OX40 and OX40L in peripheral blood of patients with primary Sjogren's syndrome].. PubMed. 29(8). 862–5. 5 indexed citations

18.

Xu, Ting. (2012). Systematic Review of Shengmai Injection for Cardiotoxicity Induced by Anthracyclines. 1 indexed citations

19.

Xu, Ting. (2012). Comparative Study on Evaluation Criteria of Economic and Technical Standard in the Essential Drugs “Double Envelope”Bidding in Provinces. Zhongguo yaofang. 1 indexed citations

20.

Xu, Ting. (2008). LORATADINE FOR SEASONAL ALLERGIC RHINITIS:A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Xiandai yufang yixue. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact